Analyst Ratings For NASDAQ:IMPV – Imperva (NASDAQ:IMPV)
Today, Royal Bank of Canada reiterated its Buy rating on NASDAQ:IMPV – Imperva (NASDAQ:IMPV) with a price target of $54.00.
Some recent analyst ratings include
- 4/23/2018-Royal Bank of Canada Reiterated Rating of Buy.
- 4/10/2018-DA Davidson initiated coverage with a Buy rating.
- 2/9/2018-Piper Jaffray Upgrade from a “Neutral ” rating to a ” Overweight” rating.
- 12/12/2017-JPMorgan Chase was Downgraded by analysts at JPMorgan Chase from a “Neutral ” rating to a ” Underweight” rating. They now have a $45.00 price target on the stock.
- On 2/20/2018 Anthony J Bettencourt, Director, sold 66,037 with an average share price of $46.98 per share and the total transaction amounting to $3,102,418.26.
- On 2/20/2018 Michael D Mooney, CRO, sold 24,454 with an average share price of $47.18 per share and the total transaction amounting to $1,153,739.72.
- On 8/24/2017 Anthony J Bettencourt, Director, sold 99,598 with an average share price of $43.59 per share and the total transaction amounting to $4,341,476.82.
- On 5/16/2017 Sunil D Nagdev, SVP, sold 4,857 with an average share price of $49.00 per share and the total transaction amounting to $237,993.00.
- On 5/15/2017 Amichai Shulman, Insider, sold 3,089 with an average share price of $48.70 per share and the total transaction amounting to $150,434.30.
- On 5/10/2017 Michael D Mooney, CRO, sold 52,356 with an average share price of $47.51 per share and the total transaction amounting to $2,487,433.56.
- On 4/17/2017 Amichai Shulman, Insider, sold 3,085 with an average share price of $41.97 per share and the total transaction amounting to $129,477.45.
Recent Trading Activity for NASDAQ:IMPV – Imperva (NASDAQ:IMPV)
Shares of NASDAQ:IMPV – Imperva closed the previous trading session at with 49.900001525878906 shares trading hands.